Close

Mylan (MYL), Gilead Enter Licensing Agreement Covering Sofosbuvir

September 15, 2014 6:32 AM EDT Send to a Friend
Mylan (NASDAQ: MYL)Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login